Illumina (ILMN) - 17 Year Stock Price History

Historical daily stock prices for Illumina since 2000 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Illumina (ILMN) as of October 20, 2017 is 209.88.

Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $30.642B $2.398B
Illumina Inc. is a leading developer of next-generation tools for the large-scale analysis of genetic variation and function. The company's tools will provide information that could be used to improve drugs and therapies, customize diagnoses and treatment, and cure disease. The company is developing a comprehensive line of products that can address the scale of experimentation and the breadth of functional analysis required to achieve the goals of molecular medicine.